The inaugural theme of the INSPIRE Scholars Drug Discovery Program is on methods and approaches to the study of GPCR signalling and pharmacology.
Drugs targeting G-protein coupled receptors (GPCRs) represent the core of modern medicine and are used for treating cancer, cardiac dysfunction, diabetes, obesity, inflammation, asthma, pain, neuropsychiatric disorders, and so on. They account for the majority of best-selling drugs and about 40% of all prescription pharmaceuticals on the market.
The four-week curriculum will provide “hands-on training” in the science and pharmacology of GPCRs with intensive modules on: computational methods; cellular and molecular methods; biophysical techniques; the pharmaceutical industry; and innovation and entrepreneurship. Taught by distinguished U of T faculty and industry experts from within the GTA pharma and biotech ecosphere. The program is designed to be highly interactive.